// App-Quantinova.ai

: Recombinant human pentraxin-2 for idiopathic pulmonary fibrosis: Design of STARSCAPE-OLE, a Phase III open label extension study

Researchers

Presenter

  • Luca Richeldi

Principal Investigators

  • Kevin J. Anstrom

  • Jürgen Behr

  • Tamera J. Corte

  • Vincent Cottin

  • Gisli Jenkins

  • Nikhil Kamath

  • Yoshikazu Inoue

  • Lutaf Islam

  • Steven D. Nathan

  • Ganesh Raghu

  • Jessie Randhawa

  • Simon L.F. Walsh

  • Fernando J. Martinez

Medical Centers

  • Clinical Research Cente, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan,

  • Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, VA, United States,

  • Department of Internal Medicine V, LMU and Asklepios Fachkliniken Gauting, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany

  • National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France,

  • NIHR, Nottingham Biomedical Research Centre, Nottingham University Hospitals, Nottingham, United Kingdom

  • Univ of Washington Medical Ctr, Seattle, Washington, United States of America

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universita Cattolica del Sacro Cuore, Rome, Italy

  • Weill Cornell Medical College - New York - United States of America

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia and University of Sydney, New South Wales, Australia

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • Duke University, Durham, North Carolina, United States

Locations

  • United States

  • United Kingdom

  • Germany

  • Italy

  • Australia

  • France

  • Japan

Companies

  • Feng Chi Biotech Cor

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Pentraxin-2

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Open Label

  • Cohort

Phase

  • III

Study Id's

  • NCT02550873

  • NCT04552899

  • NCT04594707

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved